Market News

Breaking headlines and analysis across every asset class.

Markets
MarketBeat • Sep 16, 2026
Bank of America Corp DE Buys New Shares in Cenovus Energy Inc $CVE

Bank of America Corp DE has acquired 14.9 million shares of Cenovus Energy Inc, valued at $369.7 million, representing 0.81% of the company. Institutional ownership of Cenovus Energy stands at 51.19%, with analysts maintaining a "Moderate Buy" rating and a target price of $39.00. Cenovus Energy reported strong quarterly revenue growth of 47.9% year-over-year and declared a quarterly dividend of $0.22 per share.

Markets
Yahoo Finance UK • Sep 15, 2026
TORM plc announces pricing of secondary public offering of its class A common shares

TORM plc announced the pricing of a secondary public offering of 9,000,000 of its Class A common shares by OCM Njord Holdings S.à r.l. for approximately $290,250,000. The offering is expected to close on September 16, 2026, and TORM itself is not selling any shares or receiving any proceeds. J.P. Morgan Securities LLC is acting as the sole underwriter for the offering.

Markets
Yahoo Finance Singapore • Sep 15, 2026
AI Stocks Fell, but Workday and Adobe Jumped. A Favorite AI Disruption Trade Just Flinched

Workday (WDAY) and Adobe (ADBE) stock prices rose after calls to slow down frontier AI development, in contrast to the broader AI stock market which saw declines. This shift suggests that established software platforms might have more time to integrate AI as a feature, rather than being disrupted by new AI models. Both companies showed strong AI adoption in their recent earnings reports, although long-term growth and market skepticism remain factors.

Markets
Yahoo Finance • Sep 15, 2026
Trump's Marijuana Rescheduling Push Is Back in Focus. Is Tilray Stock Finally a Buy?

The article discusses the renewed focus on President Trump's push to reschedule marijuana to Schedule III, a move that could significantly impact companies like Tilray Brands (NASDAQ: TLRY). While rescheduling wouldn't federally legalize recreational cannabis, it would ease research and expand medical marijuana opportunities, areas where Tilray already has a strong international presence. The author suggests that Tilray's improved financial standing makes it a more compelling investment now, eve

Markets
Foreign Policy Journal • Sep 15, 2026
Amazon (NASDAQ: AMZN) Sets $60 Billion Ceiling With Qualcomm (NASDAQ: QCOM) As Apple (NASDAQ: AAPL) Cuts Modem Ties

Amazon has set a potential $60 billion commercial relationship with Qualcomm for AI infrastructure, including server chips, systems, and optical connectivity. This agreement is significant for Qualcomm as Apple shifts its modem development in-house, impacting Qualcomm's revenue. The deal includes warrants for Amazon, vesting based on purchasing milestones, and aims to help Qualcomm diversify its revenue streams into data centers.

Markets
Investing.com • Sep 15, 2026
Wells Fargo sees AI slowdown as unlikely despite safety calls

Wells Fargo believes a coordinated slowdown in AI development is improbable despite calls for safety pauses from industry leaders like Anthropic and OpenAI. The bank suggests that any slowdown is more likely to stem from supply-side bottlenecks such as power availability and permit delays, rather than a consensual halt in demand within the highly competitive AI market. Wells Fargo also noted that an elongated AI buildout due to these constraints could ultimately support long-term multiples for c

Markets
Investing.com • Sep 15, 2026
Raymond James downgrades Ascendis Pharma stock rating on partnership shift

Raymond James downgraded Ascendis Pharma from Strong Buy to Outperform but maintained a $287 price target, following Ascendis Pharma's announcement that it will regain rights to TransCon metabolic and cardiovascular programs from Novo Nordisk and initiate a $400 million share repurchase. The firm notes that while this shift may prolong the timeline for significant upside, the company's fundamentals remain strong, particularly with its Yorvipath product. Other analysts, including H.C. Wainwright,

Markets
Investing.com • Sep 15, 2026
Barclays downgrades Scholar Rock stock rating on valuation

Barclays downgraded Scholar Rock (NASDAQ:SRRK) to Equalweight from Overweight and raised its price target to $58 from $55 following the FDA approval of apitegromab (Isembyld). The firm noted that the risk-reward profile is now more balanced, with future upside dependent on strong commercial execution and pipeline expansion beyond spinal muscular atrophy. Despite the approval, the company remains unprofitable, underscoring the importance of successful commercialization.

Markets
MarketBeat • Sep 15, 2026
California State Teachers Retirement System Has $574.98 Million Stake in Texas Capital Bancshares, Inc. $TCBI

The California State Teachers Retirement System significantly increased its stake in Texas Capital Bancshares, Inc. (NASDAQ:TCBI) by 9,949.4% in the second quarter, now holding 5,568,296 shares valued at $574.98 million. This makes the fund one of the largest institutional holders of TCBI stock. The article also details recent insider activity, stock performance metrics, and analyst ratings for the bank.

Get Headlines in Your Inbox

One email a day with the market-moving stories you actually need to read.